Adding Pluvicto to standard therapy in metastatic patients led to a radiographic PFS benefit, but questions remain about whether the agent belongs in the first-line setting.
Pluvicto in First-line Hormone-Sensitive Prostate Cancer?
5 days ago
5
Related
Making cancer vaccines more personal
5 days ago
9
Trending
Popular
Reduce your risk of cancer: get involved and have fun
1 year ago
223
Copyright © 2019 - 2025 | Whatiscancer.net | All Rights Reserved.







English (US) ·